Showing results (31-40 of 302) with videos related to
Sort By:
Pageof 31
The Journal of Clinical Psychiatry|August 1, 1985
Schizophreniform psychosis associated with chronic industrial toluene exposure: case reportD Goldbloom, G ChouinardPsychopharmacology|January 1, 1982
Pimozide in the treatment of newly admitted schizophrenic patientsG Chouinard, L AnnableCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1990
A guide to benzodiazepine selection. Part I: Pharmacological aspectsE Teboul, G ChouinardSchizophrenia Research|August 27, 1999
A rating scale for psychotic symptoms (RSPS): part II: subscale 2: distraction symptoms (catatonia and passivity experiences subscale 3: delusions and semi-structured interview (SSCI-RSPS)G Chouinard, R MillerProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1982
Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neurolepticsG Chouinard, S SteinbergPsychopharmacology|January 1, 1984
An early phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patientsG Chouinard, L AnnableCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 1, 1990
[The anti-koro effect of a tricyclic antidepressant]L Turnier, G ChouinardCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1979
Evidence of brain dopamine deficiency in schizophreniaG Chouinard, B D JonesJournal of Clinical Psychopharmacology|August 1, 1997
Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidolG Chouinard, P S AlbrightThe American Journal of Psychiatry|March 1, 1985
Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosusB D Jones, G ChouinardPageof 31